Inside Johnson & Johnson Vaccine Federal Pause: What Holdup Means For Georgians
The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
Mary Altaffer / Associated PRess file
This week, federal public health officials recommended a pause in the use of Johnson & Johnson’s Janssen COVID-19 vaccine. This after reports of rare, but serious, blood clots.
The FDA and Atlanta-based Centers for Disease Control and Prevention met to review this handful of serious reactions and decided it was too soon to recommend vaccinations with the J&J shot continue.
The move sent ripples through vaccination programs nationwide, including in metro Atlanta.
The CDC reported the six cases occurred in women between the ages of 18 to 48. Of those six cases, one was fatal, and a number of people were admitted to the hospital for intensive care. That handful comes out of the nearly 7 million doses administered so far in the United States.
Sam Whitehead — WABE health care reporter and host of the station’s coronavirus podcast “Did You Wash Your Hands?” — discussed what’s next for Georgia’s rollout of J&J and how it will impact Georgians in hard-to-reach, rural areas, with “All Things Considered” host Jim Burress.
Lily Oppenheimer contributed to this report.
Top Stories
